Woodline Partners’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.53M	Buy	1,291,984 +724,304	+128%	+$2.32M	0.02%	676
2025 Q4	$1.55M	Hold	567,680	–	–	0.01%	804
2025 Q3	$1.23M	Hold	567,680	–	–	0.01%	785
2025 Q2	$976K	Buy	567,680 +765	+0.1%	+$1.9K	0.01%	806
2025 Q1	$1.89M	Buy	566,915 +3,338	+0.6%	+$17.2K	0.01%	673
2024 Q4	$4.17M	Buy	563,577 +1,142	+0.2%	+$10.6K	0.03%	523
2024 Q3	$5.28M	Buy	+562,435	New	+$5.33M	0.04%	383
2024 Q2	–	Sell	-1,482,859	Closed	-$22M	–	614
2024 Q1	$22M	Sell	1,482,859 -121,847	-8%	-$1.42M	0.2%	155
2023 Q4	$13M	Buy	1,604,706 +958,411	+148%	+$5.01M	0.14%	201
2023 Q3	$2.94M	Buy	+646,295	New	+$4.22M	0.03%	366
2022 Q4	–	Sell	-261,134	Closed	-$2.5M	–	802
2022 Q3	$2.5M	Sell	261,134 -238,636	-48%	-$2.75M	0.04%	431
2022 Q2	$5.52M	Buy	499,770 +312,906	+167%	+$4.1M	0.09%	247
2022 Q1	$3.11M	Sell	186,864 -431,839	-70%	-$6.68M	0.05%	307
2021 Q4	$11.8M	Buy	618,703 +433,151	+233%	+$9.54M	0.17%	164
2021 Q3	$4.58M	Buy	+185,552	New	+$4.37M	0.08%	266
2021 Q2	–	Sell	-277,523	Closed	-$8.79M	–	611
2021 Q1	$8.79M	Buy	277,523 +255,949	+1,186%	+$10.6M	0.19%	134
2020 Q4	$1M	Sell	21,574 -177,110	-89%	-$7.03M	0.03%	209
2020 Q3	$6.54M	Buy	+198,684	New	+$6.09M	0.21%	110
2020 Q2	–	Sell	-280,498	Closed	-$8.4M	–	167
2020 Q1	$8.4M	Buy	280,498 +137,857	+97%	+$3.65M	0.6%	58
2019 Q4	$3.95M	Buy	+142,641	New	+$3.24M	0.16%	97